Use of Pharmacokinetic and Pharmacodynamic Analyses to Determine the Optimal Fixed Dosing Regimen of Iclaprim for Treatment of Serious Gram-Positive Infections

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01184-17
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology


Related search